WARSAW, Ind., Jan. 24 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH) announced today that it will conduct a meeting for investors and investment analysts on February 13, 2002, during the American Academy of Orthopaedic Surgeons meeting. The meeting will be held at the Adolphus Hotel in Dallas, beginning at 5 pm (CST).
The meeting will be hosted by Ray Elliott, Chairman and CEO; Sam Leno, Chief Financial Officer; and Scott Reinholt, Director, Investor Relations.
Products and technologies being featured at the AAOS meeting, including Minimally Invasive Solutions, Patient Lifestyle products and Trabecular Metal Technology, will be highlighted in the presentations and at a technology exhibit.
Registration will be available at the meeting site, in Grand Ballroom B.
Zimmer, based in Warsaw, Indiana, is a global leader in the design, development, manufacturing and marketing of orthopaedic reconstructive implants and fracture management products. Orthopaedic reconstructive implants restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body's natural healing process. Zimmer also manufactures and markets other products related to orthopaedic and general surgery. Zimmer was founded in 1927 and has more than 3,500 employees worldwide. For the year 2000, Zimmer recorded worldwide revenues of more than $1 billion. Zimmer became an independent, publicly traded company on August 7, 2001, when it was spun off from Bristol-Myers Squibb.
Visit Zimmer on the worldwide web at www.zimmer.com